Global Iron Drugs Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15312815 | Publishing Date : 20-Feb-2020 | No. of pages : 90
Detailed TOC of Global Iron Drugs Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Iron Drugs Revenue
1.4 Market Analysis by Type
1.4.1 Global Iron Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Drug
1.4.3 IV Drug
1.5 Market by Application
1.5.1 Global Iron Drugs Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Drugstore
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Iron Drugs Market Perspective (2015-2026)
2.2 Iron Drugs Growth Trends by Regions
2.2.1 Iron Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Iron Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Iron Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Iron Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Iron Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Iron Drugs Players by Market Size
3.1.1 Global Top Iron Drugs Players by Revenue (2015-2020)
3.1.2 Global Iron Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Iron Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Iron Drugs Market Concentration Ratio
3.2.1 Global Iron Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Iron Drugs Revenue in 2019
3.3 Iron Drugs Key Players Head office and Area Served
3.4 Key Players Iron Drugs Product Solution and Service
3.5 Date of Enter into Iron Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Iron Drugs Historic Market Size by Type (2015-2020)
4.2 Global Iron Drugs Forecasted Market Size by Type (2021-2026)
5 Iron Drugs Breakdown Data by Application (2015-2026)
5.1 Global Iron Drugs Market Size by Application (2015-2020)
5.2 Global Iron Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Iron Drugs Market Size (2015-2020)
6.2 Iron Drugs Key Players in North America (2019-2020)
6.3 North America Iron Drugs Market Size by Type (2015-2020)
6.4 North America Iron Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Iron Drugs Market Size (2015-2020)
7.2 Iron Drugs Key Players in Europe (2019-2020)
7.3 Europe Iron Drugs Market Size by Type (2015-2020)
7.4 Europe Iron Drugs Market Size by Application (2015-2020)
8 China
8.1 China Iron Drugs Market Size (2015-2020)
8.2 Iron Drugs Key Players in China (2019-2020)
8.3 China Iron Drugs Market Size by Type (2015-2020)
8.4 China Iron Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Iron Drugs Market Size (2015-2020)
9.2 Iron Drugs Key Players in Japan (2019-2020)
9.3 Japan Iron Drugs Market Size by Type (2015-2020)
9.4 Japan Iron Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Iron Drugs Market Size (2015-2020)
10.2 Iron Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Iron Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Iron Drugs Market Size by Application (2015-2020)
11 India
11.1 India Iron Drugs Market Size (2015-2020)
11.2 Iron Drugs Key Players in India (2019-2020)
11.3 India Iron Drugs Market Size by Type (2015-2020)
11.4 India Iron Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Iron Drugs Market Size (2015-2020)
12.2 Iron Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Iron Drugs Market Size by Type (2015-2020)
12.4 Central & South America Iron Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview and Its Total Revenue
13.1.3 Allergan Iron Drugs Introduction
13.1.4 Allergan Revenue in Iron Drugs Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 AMAG Pharmaceuticals
13.2.1 AMAG Pharmaceuticals Company Details
13.2.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
13.2.3 AMAG Pharmaceuticals Iron Drugs Introduction
13.2.4 AMAG Pharmaceuticals Revenue in Iron Drugs Business (2015-2020)
13.2.5 AMAG Pharmaceuticals Recent Development
13.3 Daiichi Sankyo
13.3.1 Daiichi Sankyo Company Details
13.3.2 Daiichi Sankyo Business Overview and Its Total Revenue
13.3.3 Daiichi Sankyo Iron Drugs Introduction
13.3.4 Daiichi Sankyo Revenue in Iron Drugs Business (2015-2020)
13.3.5 Daiichi Sankyo Recent Development
13.4 Pharmacosmos
13.4.1 Pharmacosmos Company Details
13.4.2 Pharmacosmos Business Overview and Its Total Revenue
13.4.3 Pharmacosmos Iron Drugs Introduction
13.4.4 Pharmacosmos Revenue in Iron Drugs Business (2015-2020)
13.4.5 Pharmacosmos Recent Development
13.5 Vifor Pharma
13.5.1 Vifor Pharma Company Details
13.5.2 Vifor Pharma Business Overview and Its Total Revenue
13.5.3 Vifor Pharma Iron Drugs Introduction
13.5.4 Vifor Pharma Revenue in Iron Drugs Business (2015-2020)
13.5.5 Vifor Pharma Recent Development
13.6 Galenica
13.6.1 Galenica Company Details
13.6.2 Galenica Business Overview and Its Total Revenue
13.6.3 Galenica Iron Drugs Introduction
13.6.4 Galenica Revenue in Iron Drugs Business (2015-2020)
13.6.5 Galenica Recent Development
13.7 Nippon Shinyaku
13.7.1 Nippon Shinyaku Company Details
13.7.2 Nippon Shinyaku Business Overview and Its Total Revenue
13.7.3 Nippon Shinyaku Iron Drugs Introduction
13.7.4 Nippon Shinyaku Revenue in Iron Drugs Business (2015-2020)
13.7.5 Nippon Shinyaku Recent Development
13.8 Sanofi
13.8.1 Sanofi Company Details
13.8.2 Sanofi Business Overview and Its Total Revenue
13.8.3 Sanofi Iron Drugs Introduction
13.8.4 Sanofi Revenue in Iron Drugs Business (2015-2020)
13.8.5 Sanofi Recent Development
13.9 Wanbang Biopharmaceutical
13.9.1 Wanbang Biopharmaceutical Company Details
13.9.2 Wanbang Biopharmaceutical Business Overview and Its Total Revenue
13.9.3 Wanbang Biopharmaceutical Iron Drugs Introduction
13.9.4 Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2015-2020)
13.9.5 Wanbang Biopharmaceutical Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Iron Drugs Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Iron Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Iron Drugs Revenue
Table 3. Ranking of Global Top Iron Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Iron Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Drug
Table 6. Key Players of IV Drug
Table 7. Global Iron Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Iron Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Iron Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Iron Drugs Market Share by Regions (2015-2020)
Table 11. Global Iron Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Iron Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Iron Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Iron Drugs Players
Table 18. Global Iron Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Iron Drugs Market Share by Players (2015-2020)
Table 20. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2019)
Table 21. Global Iron Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Iron Drugs Product Solution and Service
Table 24. Date of Enter into Iron Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Iron Drugs Market Size Share by Type (2015-2020)
Table 28. Global Iron Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Iron Drugs Market Size Share by Application (2015-2020)
Table 30. Global Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Iron Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Iron Drugs Market Share (2019-2020)
Table 34. North America Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Iron Drugs Market Share by Type (2015-2020)
Table 36. North America Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Iron Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Iron Drugs Market Share (2019-2020)
Table 40. Europe Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Iron Drugs Market Share by Type (2015-2020)
Table 42. Europe Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Iron Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Iron Drugs Market Share (2019-2020)
Table 46. China Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Iron Drugs Market Share by Type (2015-2020)
Table 48. China Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Iron Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Iron Drugs Market Share (2019-2020)
Table 52. Japan Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Iron Drugs Market Share by Type (2015-2020)
Table 54. Japan Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Iron Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Iron Drugs Market Share (2019-2020)
Table 58. Southeast Asia Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Iron Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Iron Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Iron Drugs Market Share (2019-2020)
Table 64. India Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Iron Drugs Market Share by Type (2015-2020)
Table 66. India Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Iron Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Iron Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Iron Drugs Market Share (2019-2020)
Table 70. Central & South America Iron Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Iron Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Iron Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Iron Drugs Market Share by Application (2015-2020)
Table 74. Allergan Company Details
Table 75. Allergan Business Overview
Table 76. Allergan Product
Table 77. Allergan Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 78. Allergan Recent Development
Table 79. AMAG Pharmaceuticals Company Details
Table 80. AMAG Pharmaceuticals Business Overview
Table 81. AMAG Pharmaceuticals Product
Table 82. AMAG Pharmaceuticals Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 83. AMAG Pharmaceuticals Recent Development
Table 84. Daiichi Sankyo Company Details
Table 85. Daiichi Sankyo Business Overview
Table 86. Daiichi Sankyo Product
Table 87. Daiichi Sankyo Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 88. Daiichi Sankyo Recent Development
Table 89. Pharmacosmos Company Details
Table 90. Pharmacosmos Business Overview
Table 91. Pharmacosmos Product
Table 92. Pharmacosmos Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 93. Pharmacosmos Recent Development
Table 94. Vifor Pharma Company Details
Table 95. Vifor Pharma Business Overview
Table 96. Vifor Pharma Product
Table 97. Vifor Pharma Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 98. Vifor Pharma Recent Development
Table 99. Galenica Company Details
Table 100. Galenica Business Overview
Table 101. Galenica Product
Table 102. Galenica Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 103. Galenica Recent Development
Table 104. Nippon Shinyaku Company Details
Table 105. Nippon Shinyaku Business Overview
Table 106. Nippon Shinyaku Product
Table 107. Nippon Shinyaku Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 108. Nippon Shinyaku Recent Development
Table 109. Sanofi Business Overview
Table 110. Sanofi Product
Table 111. Sanofi Company Details
Table 112. Sanofi Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 113. Sanofi Recent Development
Table 114. Wanbang Biopharmaceutical Company Details
Table 115. Wanbang Biopharmaceutical Business Overview
Table 116. Wanbang Biopharmaceutical Product
Table 117. Wanbang Biopharmaceutical Revenue in Iron Drugs Business (2015-2020) (Million US$)
Table 118. Wanbang Biopharmaceutical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Iron Drugs Market Share by Type: 2020 VS 2026
Figure 2. Oral Drug Features
Figure 3. IV Drug Features
Figure 4. Global Iron Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drugstore Case Studies
Figure 7. Others Case Studies
Figure 8. Iron Drugs Report Years Considered
Figure 9. Global Iron Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Iron Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Iron Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Iron Drugs Market Share by Players in 2019
Figure 14. Global Top Iron Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Iron Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Iron Drugs Revenue in 2019
Figure 16. North America Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Iron Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Allergan Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 25. AMAG Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AMAG Pharmaceuticals Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 27. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Daiichi Sankyo Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 29. Pharmacosmos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pharmacosmos Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 31. Vifor Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Vifor Pharma Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 33. Galenica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Galenica Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 35. Nippon Shinyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Nippon Shinyaku Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 37. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sanofi Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 39. Wanbang Biopharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Wanbang Biopharmaceutical Revenue Growth Rate in Iron Drugs Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed
Keyplayers in Global Iron Drugs Market Size, Status and Forecast 2020-2026
AllerganAMAG Pharmaceuticals
Daiichi Sankyo
Pharmacosmos
Vifor Pharma
Galenica
Nippon Shinyaku
Sanofi
Wanbang Biopharmaceutical